Navigation Links
Gerry A. Higgins, Ph.D. Joins GenomeQuest to Foster Development of Whole Genome Diagnostics
Date:6/9/2011

WESTBOROUGH, Mass., June 9, 2011 /PRNewswire/ -- GenomeQuest Inc. today announced it has appointed Gerry A. Higgins, Ph.D., a nationally recognized scientist and pioneer in genomics research, as the company's first Healthcare Innovation Officer. In his new role, Dr. Higgins will focus on applying the company's proprietary technology to the development of whole genome and multi-gene diagnostics for the medical community, working closely with clinicians at hospitals and academic research centers, and partnering with commercial laboratories and pharmaceutical companies.

"A major challenge of pushing whole genome diagnostics beyond the research project stage and toward a routine test to be used by laboratories and hospitals is how to manage and interpret massive volumes of gene sequence data," Dr. Higgins said. "I joined GenomeQuest because they offer the technology to make whole genome diagnostics available to patients today – not 10 years from now."

Dr. Higgins brings a wealth of relevant knowledge and experience in the corporate, federal and academic sectors to help fortify GenomeQuest's position as the global leader in sequence data management. Most recently, Dr. Higgins was lead author of a report from the National Institutes of Health titled Information Technology Assessment Report and Strategic Roadmap on Biomedical Informatics and Computational Biology. The report addresses how NIH can help advance personalized medicine to the clinic. He also has served as vice president for Hoffmann-La Roche Pharmaceuticals, helping integrate personalized medicine into the company's product line. Previously, he was director of clinical informatics and chief innovation officer for MedStar Health, a large ten hospital network, where he focused on the integration of genomics into electronic health records. In 2001, Dr. Higgins founded and raised financing for a start-up company, SimQuest, a Silver Spring, Maryland company that focused on biomedical informatics, medical modeling and simulation. After selling the company to Laerdal Medical Corporation, he went on to serve as US vice president of R&D.

Dr. Higgins has obtained more than $65 million in grants, contracts and corporate funding for research and development projects, and he has authored more than 330 peer-reviewed publications, books and technical monographs. Additionally, he has authored more than 15 research roadmaps in biomedical informatics, biomarker databases, medical simulation and advanced learning technologies for both federal research and non-profit organizations.

"Gerry is a critical hire for us as we advance our company into the rapidly-advancing whole genome diagnostics market," said GenomeQuest Chief Executive Officer Richard Resnick. "His knowledge and experience at the intersection of clinical care and bioinformatics will be instrumental in making us the go-to company for delivering diagnostics at multi-gene and whole genome scales."

About GenomeQuest

GenomeQuest, the global leader in sequence data management, helps life science organizations realize the full promise of genomics. The core technology of the company is the GQ-Engine—a sequence database engine that is purpose-built for storing, managing and analyzing sequence data at whole- and multi-genome scale. GenomeQuest serves nine of the top 10 pharmaceutical companies and is a research standard at Syngenta, Biogemma and other leading agricultural companies.  Learn more at www.genomequest.com.


'/>"/>
SOURCE GenomeQuest Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Yuemeng Dai, M.D., Ph.D., ear, nose and throat specialist, receives Bill Potsic Basic Science Award
2. Michael S. Watson, Ph.D., receives Am College of Medical Genetics-ACMG Foundation Presidents Award
3. Jackson Laboratory and Tufts University announce new Ph.D. track in mammalian genetics
4. Ph.D. thesis describes 35 hitherto unknown families of endogenous retroviruses
5. Autism Speaks chief science officer Geraldine Dawson, Ph.D., named Rock Star of Science
6. Ph.D. thesis opens doors to obtaining chemical products and materials using biomass as raw material
7. The Reaxys Ph.D. Prize awards innovative research in organic, organometallic and inorganic chemistry
8. Geraldine Dawson, Ph.D. of Autism Speaks appointed to NIH Interagency Autism Coordinating Committee
9. Marwan Khaled Tayeh, Ph.D., is awarded the 2010 Richard King Trainee Award
10. UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students
11. Ph.D. student in K-State plant pathology selected for international fellowship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
Breaking Biology Technology: